Marrone Bio Innovations Financials
| MBIIDelisted Stock | USD 0.80 0.00 0.00% |
With this module, you can analyze Marrone financials for your investing period. You should be able to track the changes in Marrone Bio individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Marrone |
Understanding current and past Marrone Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Marrone Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Marrone Bio's assets may result in an increase in income on the income statement.
The data published in Marrone Bio's official financial statements usually reflect Marrone Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Marrone Bio Innovations. For example, before you start analyzing numbers published by Marrone accountants, it's critical to develop an understanding of what Marrone Bio's liquidity, profitability, and earnings quality are in the context of the Basic Materials space in which it operates.
Please note, the presentation of Marrone Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Marrone Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Marrone Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Marrone Bio Innovations. Please utilize our Beneish M Score to check the likelihood of Marrone Bio's management manipulating its earnings.
Marrone Bio Stock Summary
Marrone Bio competes with Analog Devices, Jabil Circuit, FormFactor, Merit Medical, and Cumberland Pharmaceuticals. Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina. Marrone Bio operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 153 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US57165B1061 |
| Business Address | 7780 420 Brier |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| Benchmark | NYSE Composite |
| Website | www.marronebioinnovations.com |
| Phone | 530 750 2800 |
| Currency | USD - US Dollar |
You should never invest in Marrone Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Marrone Stock, because this is throwing your money away. Analyzing the key information contained in Marrone Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Marrone Bio Key Financial Ratios
Generally speaking, Marrone Bio's financial ratios allow both analysts and investors to convert raw data from Marrone Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Marrone Bio over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Marrone Bio Innovations reports annually and quarterly.Marrone Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Marrone Bio's current stock value. Our valuation model uses many indicators to compare Marrone Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marrone Bio competition to find correlations between indicators driving Marrone Bio's intrinsic value. More Info.Marrone Bio Innovations is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Marrone Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Marrone Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marrone Bio's earnings, one of the primary drivers of an investment's value.Marrone Bio Market Pulse
| Quote | 0.8 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 0.8 |
| Low | 0.8 |
| High | 0.8 |
| Volume | 0 |
| Exchange | NASDAQ |
About Marrone Bio Financials
What exactly are Marrone Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Marrone Bio's income statement, its balance sheet, and the statement of cash flows. Potential Marrone Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Marrone Bio investors may use each financial statement separately, they are all related. The changes in Marrone Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Marrone Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Marrone Bio Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Marrone Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Marrone has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Marrone Bio's financials are consistent with your investment objective using the following steps:- Review Marrone Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Marrone Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Marrone Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Marrone Bio's stock is overvalued or undervalued.
Marrone Bio April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Marrone Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Marrone Bio Innovations. We use our internally-developed statistical techniques to arrive at the intrinsic value of Marrone Bio Innovations based on widely used predictive technical indicators. In general, we focus on analyzing Marrone Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Marrone Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 27.22 | |||
| Value At Risk | (6.03) | |||
| Potential Upside | 6.42 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Marrone Stock
If you are still planning to invest in Marrone Bio Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Marrone Bio's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |